Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine. / Blomqvist, Kim J.; Skogster, Moritz O.B.; Kurkela, Mika J.; Rosenholm, Marko P.; Ahlström, Fredrik H.G.; Airavaara, Mikko T.; Backman, Janne T.; Rauhala, Pekka V.; Kalso, Eija A.; Lilius, Tuomas O.

In: Journal of Controlled Release, Vol. 344, 2022, p. 214-224.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Blomqvist, KJ, Skogster, MOB, Kurkela, MJ, Rosenholm, MP, Ahlström, FHG, Airavaara, MT, Backman, JT, Rauhala, PV, Kalso, EA & Lilius, TO 2022, 'Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine', Journal of Controlled Release, vol. 344, pp. 214-224. https://doi.org/10.1016/j.jconrel.2022.03.022

APA

Blomqvist, K. J., Skogster, M. O. B., Kurkela, M. J., Rosenholm, M. P., Ahlström, F. H. G., Airavaara, M. T., Backman, J. T., Rauhala, P. V., Kalso, E. A., & Lilius, T. O. (2022). Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine. Journal of Controlled Release, 344, 214-224. https://doi.org/10.1016/j.jconrel.2022.03.022

Vancouver

Blomqvist KJ, Skogster MOB, Kurkela MJ, Rosenholm MP, Ahlström FHG, Airavaara MT et al. Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine. Journal of Controlled Release. 2022;344:214-224. https://doi.org/10.1016/j.jconrel.2022.03.022

Author

Blomqvist, Kim J. ; Skogster, Moritz O.B. ; Kurkela, Mika J. ; Rosenholm, Marko P. ; Ahlström, Fredrik H.G. ; Airavaara, Mikko T. ; Backman, Janne T. ; Rauhala, Pekka V. ; Kalso, Eija A. ; Lilius, Tuomas O. / Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine. In: Journal of Controlled Release. 2022 ; Vol. 344. pp. 214-224.

Bibtex

@article{f873d74316294a66921b85e2c3d133c8,
title = "Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine",
abstract = "The blood-brain barrier significantly limits effective drug delivery to central nervous system (CNS) targets. The recently characterized glymphatic system offers a perivascular highway for intrathecally (i.t.) administered drugs to reach deep brain structures. Although periarterial cerebrospinal fluid (CSF) influx and concomitant brain drug delivery can be enhanced by pharmacological or hyperosmotic interventions, their effects on drug delivery to the spinal cord, an important target for many drugs, have not been addressed. Hence, we studied in rats whether enhancement of periarterial flow by systemic hypertonic solution might be utilized to enhance spinal delivery and efficacy of i.t. morphine. We also studied whether the hyperosmolar intervention affects brain or cerebrospinal fluid drug concentrations after systemic administration. Periarterial CSF influx was enhanced by intraperitoneal injection of hypertonic saline (HTS, 5.8%, 20 ml/kg, 40 mOsm/kg). The antinociceptive effects of morphine were characterized, using tail flick, hot plate and paw pressure tests. Drug concentrations in serum, tissue and microdialysis samples were determined by liquid chromatography-tandem mass spectrometry. Compared with isotonic solution, HTS increased concentrations of spinal i.t. administered morphine by 240% at the administration level (T13–L1) at 60 min and increased the antinociceptive effect of morphine in tail flick, hot plate, and paw pressure tests. HTS also independently increased hot plate and paw pressure latencies but had no effect in the tail flick test. HTS transiently increased the penetration of intravenous morphine into the lateral ventricle, but not into the hippocampus. In conclusion, acute systemic hyperosmolality is a promising intervention for enhanced spinal delivery of i.t. administered morphine. The relevance of this intervention should be expanded to other i.t. drugs and brought to clinical trials.",
keywords = "Analgesia, Drug delivery, Glymphatic system, Opioids, Osmosis, Spinal cord",
author = "Blomqvist, {Kim J.} and Skogster, {Moritz O.B.} and Kurkela, {Mika J.} and Rosenholm, {Marko P.} and Ahlstr{\"o}m, {Fredrik H.G.} and Airavaara, {Mikko T.} and Backman, {Janne T.} and Rauhala, {Pekka V.} and Kalso, {Eija A.} and Lilius, {Tuomas O.}",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
doi = "10.1016/j.jconrel.2022.03.022",
language = "English",
volume = "344",
pages = "214--224",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Systemic hypertonic saline enhances glymphatic spinal cord delivery of lumbar intrathecal morphine

AU - Blomqvist, Kim J.

AU - Skogster, Moritz O.B.

AU - Kurkela, Mika J.

AU - Rosenholm, Marko P.

AU - Ahlström, Fredrik H.G.

AU - Airavaara, Mikko T.

AU - Backman, Janne T.

AU - Rauhala, Pekka V.

AU - Kalso, Eija A.

AU - Lilius, Tuomas O.

N1 - Publisher Copyright: © 2022 The Authors

PY - 2022

Y1 - 2022

N2 - The blood-brain barrier significantly limits effective drug delivery to central nervous system (CNS) targets. The recently characterized glymphatic system offers a perivascular highway for intrathecally (i.t.) administered drugs to reach deep brain structures. Although periarterial cerebrospinal fluid (CSF) influx and concomitant brain drug delivery can be enhanced by pharmacological or hyperosmotic interventions, their effects on drug delivery to the spinal cord, an important target for many drugs, have not been addressed. Hence, we studied in rats whether enhancement of periarterial flow by systemic hypertonic solution might be utilized to enhance spinal delivery and efficacy of i.t. morphine. We also studied whether the hyperosmolar intervention affects brain or cerebrospinal fluid drug concentrations after systemic administration. Periarterial CSF influx was enhanced by intraperitoneal injection of hypertonic saline (HTS, 5.8%, 20 ml/kg, 40 mOsm/kg). The antinociceptive effects of morphine were characterized, using tail flick, hot plate and paw pressure tests. Drug concentrations in serum, tissue and microdialysis samples were determined by liquid chromatography-tandem mass spectrometry. Compared with isotonic solution, HTS increased concentrations of spinal i.t. administered morphine by 240% at the administration level (T13–L1) at 60 min and increased the antinociceptive effect of morphine in tail flick, hot plate, and paw pressure tests. HTS also independently increased hot plate and paw pressure latencies but had no effect in the tail flick test. HTS transiently increased the penetration of intravenous morphine into the lateral ventricle, but not into the hippocampus. In conclusion, acute systemic hyperosmolality is a promising intervention for enhanced spinal delivery of i.t. administered morphine. The relevance of this intervention should be expanded to other i.t. drugs and brought to clinical trials.

AB - The blood-brain barrier significantly limits effective drug delivery to central nervous system (CNS) targets. The recently characterized glymphatic system offers a perivascular highway for intrathecally (i.t.) administered drugs to reach deep brain structures. Although periarterial cerebrospinal fluid (CSF) influx and concomitant brain drug delivery can be enhanced by pharmacological or hyperosmotic interventions, their effects on drug delivery to the spinal cord, an important target for many drugs, have not been addressed. Hence, we studied in rats whether enhancement of periarterial flow by systemic hypertonic solution might be utilized to enhance spinal delivery and efficacy of i.t. morphine. We also studied whether the hyperosmolar intervention affects brain or cerebrospinal fluid drug concentrations after systemic administration. Periarterial CSF influx was enhanced by intraperitoneal injection of hypertonic saline (HTS, 5.8%, 20 ml/kg, 40 mOsm/kg). The antinociceptive effects of morphine were characterized, using tail flick, hot plate and paw pressure tests. Drug concentrations in serum, tissue and microdialysis samples were determined by liquid chromatography-tandem mass spectrometry. Compared with isotonic solution, HTS increased concentrations of spinal i.t. administered morphine by 240% at the administration level (T13–L1) at 60 min and increased the antinociceptive effect of morphine in tail flick, hot plate, and paw pressure tests. HTS also independently increased hot plate and paw pressure latencies but had no effect in the tail flick test. HTS transiently increased the penetration of intravenous morphine into the lateral ventricle, but not into the hippocampus. In conclusion, acute systemic hyperosmolality is a promising intervention for enhanced spinal delivery of i.t. administered morphine. The relevance of this intervention should be expanded to other i.t. drugs and brought to clinical trials.

KW - Analgesia

KW - Drug delivery

KW - Glymphatic system

KW - Opioids

KW - Osmosis

KW - Spinal cord

U2 - 10.1016/j.jconrel.2022.03.022

DO - 10.1016/j.jconrel.2022.03.022

M3 - Journal article

C2 - 35301056

AN - SCOPUS:85126518281

VL - 344

SP - 214

EP - 224

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -

ID: 344805936